Yunnan medicine Jiangzhi ointment alleviates hyperlipid-induced hepatocyte ferroptosis by activating AMPK and promoting autophagy

Xin Hong; Haijing Liu; Hongli Sun; Yan Zhuang; Ming Xiao; Shaoping Li; Yandong Li; Ming Jing

doi:10.1007/s10616-025-00737-3

Back

Yunnan medicine Jiangzhi ointment alleviates hyperlipid-induced hepatocyte ferroptosis by activating AMPK and promoting autophagy

Cytotechnology 77(2)

Article 2025 English

Abstract

1 min read

Nonalcoholic fatty liver disease (NAFLD) is a serious public health problem worldwide. The purpose of this study was to investigate whether Yunnan medicine

Discussion(0)

No comments yet. Be the first to comment.

Related publications

Article2019

Current Status in Testing for Nonalcoholic Fatty Liver Disease (NAFLD) and Nonalcoholic Steatohepatitis (NASH)

Hannah K. Drescher, Sabine Weiskirchen, Ralf Weiskirchen

Article2014

Clinical Features of Pediatric Nonalcoholic Fatty Liver Disease

R. Constance Wiener, Peter J Barnes, Matthew J. Gurka, Mark D. DeBoer, Jeremy P. Middleton

Article2024

How the liver transcriptome and lipid composition influence the progression of nonalcoholic fatty liver disease to hepatocellular carcinoma in a murine model

Marvin Leopold, Paola Berenice Mass Sanchez, Marinela Krizanac, Paula Štancl, Rosa Karlić, Patricia Prabutzki, Victoria Parafianczuk, Jürgen Schiller, Anastasia Asimakopoulos, Kathrin M. Engel, Ralf Weiskirchen

Article2009

Upregulation of human acyl-CoA synthetase 5 in fatty liver degeneration sensitizes for hepatocellular apoptosis

Andrea Reinartz, Kerstin Raupach, Christian Liedtke, Ralf Weiskirchen, Nikolaus Gaßler

Letter2009

The genes that underlie fatty liver disease: The harvest has begun #

Ralf Weiskirchen, Hermann E. Wasmuth, Kris V. Kowdley, Geoffrey W. McCaughan, Christian Trautwein